Recalcitrant Trichomonas Vaginalis Infections Successfully Treated With Vaginal Acidification

Journal of Obstetrics and Gynaecology Canada

Volumn 30, Issue 1, 2008, Pages 55-58

  Aggarwal, Anjali ^a   Shier, R Michael ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

Recalcitrant; Resistant; Treatment; Trichomonas vaginalis; Trichomoniasis

Indexed keywords

ACETIC ACID; BORIC ACID; CLOTRIMAZOLE; CONJUGATED ESTROGEN; CRYSTAL VIOLET; FLUCONAZOLE; METRONIDAZOLE; PAROMOMYCIN; POVIDONE IODINE; ANTIPROTOZOAL AGENT; TOPICAL ANTIINFECTIVE AGENT;

ADULT; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM CULTURE; CASE REPORT; COLPOSCOPY; DEBRIDEMENT; DISEASE SEVERITY; DOSE RESPONSE; DRUG HYPERSENSITIVITY; FEMALE; GYNECOLOGIC CARE; HUMAN; MIDDLE AGED; NONHUMAN; RESPIRATORY TRACT DISEASE; SEXUAL BEHAVIOR; SINGLE DRUG DOSE; THERAPY; TREATMENT OUTCOME; TRICHOMONIASIS; URTICARIA; VAGINA MYCOSIS; VAGINAL ACIDIFICATION; VAGINITIS; ANIMAL; DRUG EFFECT; PARASITOLOGY; PH; RECURRENT DISEASE; TRICHOMONAS VAGINALIS; VAGINA;

ACETIC ACID; ADULT; ANIMALS; ANTI-INFECTIVE AGENTS, LOCAL; ANTIPROTOZOAL AGENTS; BORIC ACIDS; CLOTRIMAZOLE; FEMALE; GENTIAN VIOLET; HUMANS; HYDROGEN-ION CONCENTRATION; MIDDLE AGED; RECURRENCE; TREATMENT OUTCOME; TRICHOMONAS VAGINALIS; TRICHOMONAS VAGINITIS; VAGINA;

EID: 41149155005     PISSN: 17012163     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1701-2163(16)32714-1     Document Type: Article

References (34)

1. WHO: Trichomoniasis. Available at: . Accessed October 29, 2007. http://www.who.int.
2. Anderson M.R., Klink K., Cohrssen A. Evaluation of vaginal complaints. JAMA 2004, 291:1368-1379.
3. Cudmore S.L., Delgaty K.L., Hayward-McClelland S.F., Petrin D.P., Garber G.E. Treatment of infections caused by metronidazole-resistant Trichomonas vaginalis. Clin Microbiol Rev 2004, 17(4):783-793.
4. Soper D.E., Bump R.C., Hurt W.G. Bacterial vaginosis and trichomoniasis vaginitis are risk factors for cuff cellulitis after abdominal hysterectomy. Am J Obstet Gynecol 1990, 163:1016.
5. Grodstein F., Goldman M.B., Cramer D.W. Relation of tubal infertility to history of sexually transmitted diseases. Am J Epidemiol 1993, 137:577.
6. Zhang Z.F., Begg C.B. Is Trichomonas vaginalis a cause of cervical neoplasia? Results from a combined analysis of 24 studies. Int J Epidemiol 1994, 23:682.
7. Cotch M.F., Pastorek J.G., Nugent R.P., Hillier S.L., Gibbs R.S., Martin D.H., et al. Trichomonas vaginalis associated with low birth weight and preterm delivery. The Vaginal Infections and Prematurity Study Group. Sex Transm Dis 1997, 24:353.
8. Cameron D.E., Padian N.S. Sexual transmission of HIV and the epidemiology of other sexually transmitted diseases. AIDS 1990, 4(Suppl. 1):S99-S103.
9. Cosar C., Julou L. Activity of 1-(2-hydroxylethyl)-2-methyl-5-nitroimidazole (8823 RP) against experimental Trichomonas vaginalis infection. Ann Inst Pasteur 1959, 96:238-241.
10. Thurner J., Meingassner J.G. Isolation of Trichomonas vaginalis resistant to metronidazole. Lancet 1978, ii:738.
11. Waters L.J., Dave S.S., Deayton J.R., French P.D. Recalcitrant Trichomonas vaginalis infection-a case series. Int J STD AIDS 2005, 16:505-509.
12. Lossick J.G. Chemotherapy of nitro-imidazole resistant vaginal trichomoniasis. Acta Univ Carol Biol 1991, 30:533-545.
13. Sexually Transmitted Diseases Treatment Guidelines Centers for Disease Control and Prevention Available at:, Accessed October 30, 2007. http://www.cdc.gov/std/treatment/2006/vaginal-discharge.htm#vagdis3.
14. Lossick J.G. Treatment of sexually transmitted vaginosis/vaginitis. [Review]. Rev of Infect Dis 1990, 12(Suppl):S665-S681.
15. Sobel J.D., Nyirjesy P., Brown W. Tinidazole therapy for metronidazole-resistant vaginal trichomoniasis. Clin Infect Dis 2001, 33:1341-1346.
16. Hager W.D. Treatment of metronidazole-resistant Trichomonas vaginalis with tinidazole. Sex Transm Dis 2004, 31(6):343-345.
17. Njirjesy P., Sobel J.D., Weitz M.V., et al. Difficult to treat trichomoniasis: results with paromycin cream. Clin Infect Dis 1998, 26:986-988.
18. Poppe W.A. Nitro-imidazole resistant vaginal trichomoniasis treated with paromycin. Eur J Obstet Gynaecol Reprod Biol 2001, 96:119-120.
19. Ratzan J.J. Monoilial and trichomonal vaginitis-topical treatment with povidone-iodine preparations. Calif Med 1969, 110:24-27.
20. Walker P.P., Hall R.E., Wilson J.D. Arsenical pessaries in the treatment of metronidazole-resistant Trichomonas vaginalis. Int J STD AIDS 1997, 8:473-474.
21. Chen M.Y., Smith N.A., Fox E.F., Bingham J.S., Barlow D. Acetarsol pessaries in the treatment of metronidazole resistant Trichomonas vaginalis. Int J STD AIDS 1999, 10:277-280.
22. Watson P.G., Pattman R.S. Arsenical pessaries in the successful elimination of metronidazole-resistant Trichomonas vaginalis. Int J STD AIDS 1996, 7:296-297.
23. DuBouchet L., Spence M.R., Rein M.F., Danzig M.R., McCormack W.M. Multicenter comparison clotrimazole vaginal tablets, oral metronidazole, and vaginal suppositories containing sulphanilamide, aminacrine hydrochloride, and allantoin in the treatment of symptomatic trichomoniasis. Sex Transm Dis 1997, 24:156-160.
24. Schnell J.D. The incidence of vaginal candida and trichomonal infections and the treatment of Trichomonas vaginitis with clotrimazole. Postgrad Med J 1974, 50:81-83.
25. Yu H., Tak-Yin M. The efficacy of povidone-iodine pessaries in a short, low-dose treatment regimen on candidal, trichomonal and non-specific vaginitis. Postgrad Med J 1993, 69:558-561.
26. Wong C.A., Wilson P.D., Chear T.A. Povidone-iodine in the treatment of metronidazole-resistant Trichomonas vaginalis. Austr N Z J Obstet Gynaecol 1990, 30:169-171.
27. Mammen-Tobin A., Wilson J.D. Management of metronidazole-resistant Trichomonas vaginalis-a new approach. Int J STD AIDS 2005, 16(7):488-490.
28. Bassiouni S.O., Riad R.M. Nonoxynol 9 as an additive therapy in metronidazole-resistant cases of vaginal trichomoniasis. J Egypt Soc Paras 2005, 35(2):551-562.
29. Antonelli N.M., Diehl S.J., Wright J. A randomized trial of intra-vaginal nonoxynol-9 versus oral metronidazole in the treatment of vaginal trichomoniasis. Am J Obstet Gynecol 2000, 182:1008-1010.
30. Houang E.T., Ahmet Z., Lawrence A.G. Successful treatment of four patients with recalcitrant vaginal trichomoniasis with a combination of zinc sulphate douche and metronidazole therapy. Sex Transm Dis 1997, 24(2):116-119.
31. Fiori P.L., Rappelli P., Addis M.F., et al. Trichomonas vaginalis haemolysis: pH regulates a contact-independent mechanism based on pore-forming proteins. Microb Pathog 1996, 20(2):109-118.
32. Meysick K.C., Garber G.E. Interactions between Trichomonas vaginalis and vaginal flora in a mouse model. J Parasitol 1992, 78(1):157-160.
33. Hanna N.F., Taylor-Robinson D., Kalodiki-Karamanoli M., Harris J.R., McFayden I.R. The relation between vaginal pH and the microbiological status in vaginitis. BJOG 1985, 92(12):1267-1271.
34. Petrin D., Delgaty K., Bhatt R., Garber G. Clinical and microbiological aspects of Trichomonas vaginalis. Clin Microbiol Rev 1998, 11(2):300-317.